Is a complete IART research report available?

No complete published report is available for Integra LifeSciences Holdings Corporation (IART) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Integra LifeSciences Holdings Corporation (IART)

NASDAQ: IART · USD

$18.6

-0.26 (-1.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first IART analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.4B
Revenue (ttm)	1.6B
Net income (ttm)	-495.8M
EPS (ttm)	-$6.46
Shares out	77.8M
P/E (forward)	7.5x
Volume	609,243
Beta	1.22
Price target	$18.6

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All IART indicators

Market & fundamental data

Available fields

249

Groups with data

Currency

USD

Showing 249 of 249 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000917520
Company name	Integra LifeSciences Holdings Corporation
Country	United States
Country code	US
Cusip	457985208
Employees	4,427
Employees Change	31%
Employees Change Percent	0.71
Enterprise value	$3.2B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	40.3
Industry PE Fwd	18.64
IPO Date	1995-08-16
Isin	US4579852082
Last refreshed	2026-07-24
Market cap	$1.4B
Market cap category	Small-Cap
Price	$18.56
Price currency	USD
Rev Per Employee	371,472.78x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	3841
Symbol	IART
Website	https://www.integralife.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-34.34%
EV Sales Forward	1.91x
EV/EBIT	71.6x
EV/EBITDA	16.26x
EV/FCF	789.04x
EV/Sales	1.96x
FCF yield	0.28%
Forward P/E	7.54x
P/B ratio	1.39x
P/S ratio	0.88x
PE Ratio10 Y	62.8x
PE Ratio5 Y	38.15x
PEG ratio	1.03x
PS Forward	0.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.73%
EBITDA Margin	12.04%
FCF margin	0.25%
Gross margin	56.72%
Gross Profit	$932.7M
Gross Profit Growth	-2.28%
Gross Profit Growth Q	6.17%
Gross Profit Growth3 Y	-1.71%
Gross Profit Growth5 Y	1.17%
Net Income	$-495.8M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-32.59%
Profit Margin	-30.15%
Profit Per Employee	$-111,994
ROA	2.54
Roa5y	2.88
ROCE	1.39
ROE	-38.64
Roe5y	-3.09
ROIC	5.51
Roic5y	5.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.28%
Cagr15y	-0.96%
Cagr1y	54.07%
Cagr20y	0.39%
Cagr3y	-25.76%
Cagr5y	-22.68%
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth3 Y	-72.66%
FCF Growth5 Y	-55.08%
OCF Growth	-30.21%
OCF Growth10 Y	-3.14%
OCF Growth3 Y	-33.8%
OCF Growth5 Y	-22.29%
Revenue Growth	1.24x
Revenue Growth Q	2.42x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	1.73x
Revenue Growth5 Y	3.61x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.43
Assets	$3.6B
Cash	$265.5M
Current Assets	$1.2B
Current Liabilities	$346.8M
Debt	$2B
Debt EBITDA	$10.31
Debt Equity	$1.96
Debt FCF	$500
Equity	$1B
Interest Coverage	0.5
Liabilities	$2.5B
Long Term Assets	$2.4B
Long Term Liabilities	$2.2B
Net Cash	$-1.8B
Net Cash By Market Cap	$-123
Net Debt EBITDA	$8.96
Net Debt Equity	$1.7
Net Debt FCF	$435
Tangible Book Value	$-676.2M
Tangible Book Value Per Share	$-8.69
WACC	6.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.38
Inventory Turnover	1.51
Net Working Capital	$613.4M
Quick ratio	1.53
Working Capital	$825.2M
Working Capital Turnover	$3.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.13%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-53.04%
1Y total return	54.03%
200-day SMA	13.2
3Y total return	-59.08%
50-day SMA	17.13
50-day SMA vs 200-day SMA	50over200
5Y total return	-72.36%
All Time High	77.4
All Time High Change	-76.02%
All Time High Date	2021-04-28
All Time Low	1.5
All Time Low Change	1,137.33%
All Time Low Date	1999-01-15
ATR	0.78
Beta	1.22
Beta1y	2.16
Beta2y	1.8
Ch YTD	49.44
High	18.87
High52	20.26
High52 Date	2026-07-16
High52ch	-8.39%
Low	18.29
Low52	8.7
Low52 Date	2026-03-20
Low52ch	113.33%
Ma50ch	8.38%
Price vs 200-day SMA	40.58%
RSI	54.82
RSI Monthly	47.94
RSI Weekly	69.5
Sharpe ratio	0.95x
Sortino ratio	1.57
Total Return	-0.13%
Tr YTD	49.44
Tr15y	-13.41%
Tr1m	5.46%
Tr1w	-6.5%
Tr3m	72.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	2
Analyst Price Target Top	$18
Analyst Ratings	Hold
Analyst Ratings Top	Hold
Earnings EPS Estimate	$0.48
Earnings EPS Estimate Growth	6.67
Earnings Revenue Estimate	418,014,320x
Earnings Revenue Estimate Growth	0.58x
Operating Income	$155.2M
Operating Income Growth	-10.25
Operating Income Growth Q	29.57
Operating Income Growth3 Y	-16.9
Operating Income Growth5 Y	-7.66
Operating margin	9.44
Price target	$18.63
Price Target Change	$0.38
Price Target Change Top	$-3.02

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	58,696,348%
Float Percent	75.45%
Net Borrowing	20,567,000
Shares Insiders	3.6%
Shares Institutions	87.01%
Shares Out	77,796,903
Shares Qo Q	0.23%
Shares Yo Y	0.13%
Short Float	10.89%
Short Ratio	6.52
Short Shares	8.22

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-17.8M
Average Volume	940,917.1x
Bv Per Share	13.4
CAPEX	$-67.4M
Ch10y	-53.04
Ch15y	-21.74
Ch1m	5.46
Ch1w	-6.5
Ch1y	54.03
Ch20y	-2.37
Ch3m	72.65
Ch3y	-59.08
Ch5y	-72.36
Ch6m	52.26
Change	-1.38%
Change From Open	0.11
Close	18.82
Days Gap	-1.49
Depreciation Amortization	153,074,000
Dollar Volume	11,307,550.1
Earnings Date	2026-07-29
Earnings Time	bmo
EBIT	$45M
EBITDA	$198M
EPS	$-6.46
F Score	5
FCF	$4.1M
FCF EV Yield	0.13x
FCF Per Share	$0.05
Financing CF	1,255,000
Fiscal Year End	December
Founded	1,989
Goodwill	613,247,000
Income Tax	$-40.1M
Investing CF	-86,991,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2017-01-04
Last Split Type	Forward
Last10k Filing Date	2026-02-26
Ma150	13.15
Ma150ch	41.11%
Ma20	18.49
Ma20ch	0.38%
Net CF	-2,295,000
Next Earnings Date	2026-07-29
Open	18.54
Optionable	Yes
P FCF Ratio	353.9
P OCF Ratio	20.21
Position In Range	46.55
Ppne	584,079,000
Price Date	2026-07-23
Price EBITDA	$7.29
Relative Volume	0.65x
Revenue	1,644,510,000x
SBC By Revenue	1.33x
Share Based Comp	21,878,000
Tax By Revenue	-2.44x
Tr20y	8.02%
Tr6m	52.26%
Us State	New Jersey
Volume	609,243
Z Score	1.29

Integra LifeSciences Holdings Corporation (IART)

Coverage state: Market snapshot only — no published research

Generate the first IART analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · IART

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IART indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on IART

Frequently asked questions